The two entities will collaborate on work focused on "fields of energy and climate; quantum computing and artificial intelligence; global health and medicine; and urban futures." Photo via Rice University

Rice University and Université Paris Sciences & Lettres signed a strategic partnership agreement last week that states that the two institutions will work together on research on some of today's most pressing subject matters.

According to an announcement made on May 13 in Paris, the two schools and research hubs will collaborate on work focused on "fields of energy and climate; quantum computing and artificial intelligence; global health and medicine; and urban futures."

The partnership allows Rice to expand its presence in France, after launching its Rice Global Paris Center about two years ago.

Université PSL consists of 11 top research institutes in France and 2,900 world-class researchers and 140 research laboratories.

“We are honored and excited to partner with Paris Sciences and Lettres University and join forces to advance bold innovation and find solutions to the biggest global challenges of our time,” Rice President Reginald DesRoches said in a statement. “The unique strengths and ambitions of our faculty, students, scholarship and research are what brings us together, and our passion and hope to build a better future for all is what will drive our partnership agenda. Representing two distinct geographic, economic and cultural regions known for ingenuity and excellence, Rice and PSL’s efforts will know no bounds.”

Rice and Université PSL plan to host conferences around the four research priorities of the partnership. The first took place last week at the Rice Global Paris Center. The universities will also biannually select joint research projects to support financially.

“This is a global and cross-disciplinary partnership that will benefit from both a bottom-up, research-driven dynamic and a top-down commitment at the highest level,” PSL President Alain Fuchs said in a statement. “The quality and complementarity of the researchers from PSL and Rice who mobilized for this event give us reason to believe that this partnership will get off to a rapid and productive start. It will offer a strong framework to all the PSL schools for developing collaborations within their areas of strength and their natural partners at Rice.”

Rice launched its Rice Global Paris Center in June 2022 in a historic 16th-century building in Le Marais. At the time it, the university shared that it was intended to support Rice-organized student programs, independent researchers, and international conferences, as well as a satellite and hub for other European research activity.

"Rice University's new home in the Marais has gone from an idea to a mature relative with a robust program of faculty research summits, student opportunities, cultural events and community engagement activities," Caroline Levander, Rice's global Vice President, said at the announcement of the partnership last week.

Click here to learn more about the Global Paris Center.

Last month, University of Houston also signed a memorandum of understanding with Heriot-Watt University in Scotland to focus on hydrogen energy solutions.

------

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”